International Biotechnology Trust PLC Apellis Pharmaceuticals, Inc. Transaction History

International Biotechnology Trust PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$76.68 - $93.31 $7.51 Million - $9.14 Million	98,000 Added 309.15%	129,700 $11.8 Million
Q4 2022 Feb 01, 2023	BUY	$43.24 - $61.04 $1.37 Million - $1.93 Million	31,700 New	31,700 $1.64 Million
Q2 2022 Aug 16, 2022	SELL	$35.07 - $59.21 $1.09 Million - $1.84 Million	-31,030 Reduced 95.48%	1,470 $32.5 Million
Q4 2021 Feb 15, 2022	BUY	$30.74 - $49.16 $999,050 - $1.6 Million	32,500 New	32,500 $1.54 Million
Q3 2021 Nov 12, 2021	SELL	$31.4 - $69.84 $734,760 - $1.63 Million	-23,400 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$40.8 - $57.39 $954,719 - $1.34 Million	23,400 New	23,400 $1 Million

310

113M

3.85M

1.09M

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.29B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.